Trigeminoautonome Kopfschmerzen

Im Vergleich zur Migräne und zum Kopfschmerz vom Spannungstyp sind trigeminoautonome Kopfschmerzen (TAK) zwar selten, aber die erhebliche Beeinträchtigung und die nicht unerhebliche Prävalenz [1] (z. B. Clusterkopfschmerz 0,1%) machen TAK zu wichtigen Diagnosen. Die korrekte Diagnosestellung erfolgt allerdings leider oft verzögert. Dieser Beitrag gibt einen Überblick über das diagnostische Vorgehen und die therapeutischen Möglichkeiten bei TAK.

Abstract

Compared with migraine and tension-type headache, trigeminal autonomic cephalgias (TAC) are rare, but the resulting significant impairment and the not irrelevant prevalence (e. g., cluster headache 0.1%) make TACs important diagnoses. Unfortunately, the correct diagnosis is often delayed. This article provides an overview of the diagnostic approach and therapeutic options in TACs.

Schlüsselwörter

SUNCT - Clusterkopfschmerz - Hemikranie - Therapie - Diagnose

Key words

SUNCT - Cluster headache - hemicrania - therapy - diagnosis

Publication History

Article published online:
16 March 2022

• Literatur

• 1 Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders. 3rd ed. Cephalalgia 2018; 38: 1-211
• 2 Goadsby PJ, Holland PR, Martins-Oliveira M. et al. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev 2017; 97: 553-622
• 3 Obermann M, Holle D, Nagel S. Functional neuroimaging in trigeminal autonomic cephalalgias. Ann Indian Acad Neurol 2018; 21: S51-S56
• 4 Edvardsson B. Symptomatic cluster headache: a review of 63 cases. Springerplus 2014; 3: 64
• 5 Favier I, van Vliet JA, Roon KI. et al. Trigeminal autonomic cephalgias due to structural lesions: a review of 31 cases. Arch Neurol 2007; 64: 25-31
• 6 Mitsikostas DD, Ashina M. EHF committee. et al. European headache federation consensus on technical investigation for primary headache disorders. J Headache Pain 2015; 17: 5
• 7 Fischera M, Marziniak M, Gralow I. et al. The incidence and prevalence of cluster headache: a meta-analysis of population- based studies. Cephalalgia 2008; 28: 614-618
• 8 Manzoni GC, Taga A, Russo M. et al. Age of onset of episodic and chronic cluster headache – a review of a large case series from a single headache centre. J Headache Pain 2016; 17: 44
• 9 Rozen TD, Fishman RS. Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache 2012; 52: 99-113
• 10 Govare A, Leroux E. Licit and Illicit Drug Use in Cluster Headache. Curr Pain Headache Rep 2014; 18: 413
• 11 Gaul C, Christmann N, Schröder D. et al. Differences in clinical characteristics and frequency of accompanying migraine features in episodic and chronic cluster headache. Cephalalgia 2012; 32: 571-577
• 12 Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002; 58: 354-361
• 13 Burish MJ, Rozen TD. Trigeminal Autonomic Cephalalgias. Neurol Clin 2019; 37: 847-869
• 14 Gaul C, Diener H-C, Silver N. et al. Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): A randomised controlled study. Cephalalgia 2016; 36: 534-546
• 15 Goadsby PJ, de Coo IF, Silver N. et al. Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study. Cephalalgia 2018; 38: 959-969
• 16 Goadsby PJ, Cohen AS, Matharu MS. Trigeminal autonomic cephalalgias: diagnosis and treatment. Curr Neurol Neurosci Rep 2007; 7: 117-125
• 17 Obermann M, Nägel S, Ose C. et al. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Lancet Neurol 2021; 20: 29-37
• 18 Leroux E, Ducros A. Occipital injections for trigemino-autonomic cephalalgias: evidence and uncertainties. Curr Pain Headache Rep 2013; 17: 325
• 19 Abdel-Maksoud MB, Nasr A, Abdul-Aziz A. Lithium treatment in cluster headache: review of literature. Eur J Psychiat 2009; 23: 53-60
• 20 Sostak P, Krause P, Förderreuther S. et al. Botulinum toxin type-A therapy in cluster headache: an open study. J Headache Pain 2007; 8: 236-241
• 21 Ruscheweyh R, Broessner G, Goßrau G. et al. Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts. Cephalalgia 2020; 40: 1574-1584
• 22 Giani L, Proietti Cecchini A, Leone M. Cluster headache and TACs: state of the art. Neurol Sci 2020; 41: 367-375
• 23 Boes CJ, Dodick DW. Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients. Headache 2002; 42: 699-708
• 24 Cittadini E, Matharu MS, Goadsby PJ. Paroxysmal hemicrania: a prospective clinical study of 31 cases. Brain 2008; 131: 1142-1155
• 25 Ramusino MC, Perini G, Antonaci F. et al. The Treatment of Trigeminal Autonomic Cephalalgias: An Overview. J Oral Facial Pain Headache 2019; 33: 89-104
• 26 Naegel S, Holle D, Obermann M. Structural imaging in cluster headache. Curr Pain Headache Rep 2014; 18: 415